CageCapture Ltd is a University of Liverpool spin-out company, established in October 2019, which has developed new indoor air pollution technology. CageCapture is based in the Materials Innovation Factory.
CageCapture was formed to commercialise new organic materials invented by Dr Ming Liu and Professor Andrew Cooper, from the University’s Department of Chemistry. Researchers at the University designed and synthesised new cage molecule solids that act like a ‘cage prison’. These materials can capture low concentration pollutants using a combination of chemical and physical adsorption.
The patented technology has proven to efficiently capture the most common indoor air pollutant, formaldehyde, even at low levels and in humid conditions.
Nidor is a spin-out company, founded by the University of Liverpool, the University of the West of England, Bristol, the University of Bristol and The Wellcome Trust. Chris Probert, Professor of Gastroenterology at the University of Liverpool’s Institute of Translational Medicine is co-inventor of the technology.
The company aims to provide a service to support the diagnosis of a range of disorders based on gases emitted from biological samples. The first products being developed by Nidor will address the diagnosis and management of Inflammatory bowel syndrome (IBS), followed by inflammatory bowel disease.
For the first time ever, Nidor Diagnostics will be able to positively diagnose IBS and help patients to get the correct treatment. The company has recently agreed to partner with an accredited clinical laboratory, licensed to undertake trials for regulatory work.
Meta Additive is a University of Liverpool spin-out company, established in October 2019, which is at the forefront of developing next generation additive manufacturing technologies to extend 3D printing to a 4D future. The company’s technology is based on intellectual property arising from the research group of Dr Kate Black, from the School of Engineering.
Meta Additive focuses on using a chemical approach to additively manufacture metal and ceramic components for mass manufacturing. It has already developed several innovative patented technologies such as a Binder Jet Printing system with unrivalled performance advantages, including high densities and low shrinkage rate.
The company recently secured a £1.2m Innovate UK SMART grant to drive forward their technology, matched with investment from the University’s Enterprise Investment Fund.
PhenUtest Diagnostics Ltd is a University of Liverpool spin-out company taking forward state-of-the-art medical device technology that aims to revolutionise the diagnosis of Urinary Tract Infections (UTIs).
Every year, over 100 million people are diagnosed with UTIs. One in two women encounters it at some point in their life, making it a major problem worldwide. The infections are responsible for over 22% of the UK’s antibiotic prescriptions.
The new company, PhenUtest, is commercialising technology created at the University enabling a 30-minute sample to diagnosis for antimicrobial susceptibility test for UTI suspected samples. This will ensure that the patient gets the correct antibiotic in their first GP visit. The new diagnostic tests are rapid, accurate and a more cost-effective way to diagnose UTIs.
Polymer Mimetics is a joint venture between the University of Liverpool and Scott Bader Company Ltd, based in the Liverpool Science Park. It builds upon a new polymerisation process developed by Professor Steve Rannard from the University’s Department of Chemistry. The venture was launched in October 2019 with a commitment of almost £1 million in funding over 3 years from Scott Bader.
The technology takes widely available chemical building blocks and, in a highly scalable process, transforms them into superior performance polymeric products with the potential to engineer in degradability. It is envisaged that this new generation of materials will have broad applicability in several markets such as coatings, composites and speciality additives.
Porous Liquid Technologies Ltd
In 2018 The University of Liverpool and Queen’s University Belfast set up a joint-venture spin-out company called Porous Liquid Technologies Ltd to take forward a new class of materials. Invented by Professor Andy Cooper from the University’s Department of Chemistry and researchers from Queen’s University Belfast, this venture was formed around jointly created Intellectual Property developed for a broad range of technological applications.
Porous liquids are a new class of liquid materials that contain microscopic cavities or pores, each the size of a single molecule. They hold up to 10,000 times the number of cavities found in conventional liquids, and up to around 20 per cent of the liquid is space – creating new substances with a far greater absorption capacity than the base solvents.
Robotiz3d Ltd is a spinout company from the University’s School of Engineering. Dr Paolo Paoletti and Dr Sebastiano Fichera have been developing and trialling the technology over the past four years. The company was founded with investment from a private investor, alongside the University’s Enterprise Investment Fund, and has also been successful in securing grant funding.
Robotiz3d build advanced detection and repair systems embedded in autonomous robotic platforms to address the expanding need for automated road maintenance. In addition to reducing risks to maintenance crews, the cost of repair, and damage-fix timescales, the system’s AI capabilities can also predict road conditions, thus facilitating the advancement from reactive to preventative road maintenance.
Tandem Nano Ltd (TNL) is a University of Liverpool spin-out, established in April 2019, which focuses on the reformulation of existing active ingredients. Tandem is transforming the delivery of active compounds in industries as diverse as pharmaceuticals to agrochemicals.
Developed by a core team of scientists lead by Professor Andrew Owen, Department of Molecular and Clinical Pharmacology, and Steve Rannard from the Department of Chemistry, the Tandem technology has already been shown to have strong commercial potential and has secured commercial contracts with a number of major players in a variety of sectors.
Tandem secured significant pre-seed funding from the UoL Enterprise fund to begin operations and secure its first client contracts and is now building significant value, based on its strong technology platform and IP portfolio.
Back to: Collaborate with us